Issue Navigation
-
Policy Forum
-
80-88
Accessibility of drugs for rare diseases in China: Policies and current situation
Yang Y, Kang Q, Hu JH, Kong FX, Tang M, He JJ, Jin CL
Intractable Rare Dis Res. 2019; 8(2):80-88.
DOI: 10.5582/irdr.2019.01068
-
89-97
Incidence and prevalence of 121 rare diseases in China: Current status and challenges.
He JJ, Tang M, Zhang XY, Chen D, Kang Q, Yang Y, Hu JH, Jin CL, Song PP
Intractable Rare Dis Res. 2019; 8(2):89-97.
DOI: 10.5582/irdr.2019.01066
-
98-107
Lu YQ, Zhang SE, Wang YZ, Ren XZ, Han JX
Intractable Rare Dis Res. 2019; 8(2):98-107.
DOI: 10.5582/irdr.2019.01064
-
108-112
Laparoscopic treatment of median arcuate ligament syndrome.
Sun ZP, Zhang DD, Xu GZ, Zhang NW
Intractable Rare Dis Res. 2019; 8(2):108-112.
DOI: 10.5582/irdr.2019.01031
-
113-119
Cui XX, Cui YZ, Shi L, Luan J, Zhou XY, Han JX
Intractable Rare Dis Res. 2019; 8(2):113-119.
DOI: 10.5582/irdr.2019.01025
-
120-128
Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease.
Satoh J, Kino Y, Yanaizu M, Ishida T, Saito Y
Intractable Rare Dis Res. 2019; 8(2):120-128.
DOI: 10.5582/irdr.2019.01049
-
129-133
A potential significance of circ_0024169 down regulation in angiosarcoma tissue.
Nakashima S, Jinnin M, Ide M, Kajihara I, Igata T, Harada M, Masuguchi S, Fukushima S, Masuzawa M, Masuzawa M, Amoh Y, Ihn H
Intractable Rare Dis Res. 2019; 8(2):129-133.
DOI: 10.5582/irdr.2019.01034
-
134-137
Heart rate variability in a patient with alternating hemiplegia.
Nakashima T, Yasuda K, Kobayashi M, Wada H, Ishii A, Hirose S
Intractable Rare Dis Res. 2019; 8(2):134-137.
DOI: 10.5582/irdr.2019.01060
-
138-141
Tumefactive fibroinflammatory lesion successfully treated with Rituximab.
Bishop J, Bryan L, Savage N, Byrd JK
Intractable Rare Dis Res. 2019; 8(2):138-141.
DOI: 10.5582/irdr.2019.01061
-
142-145
A novel mutation in TTN gene in a Saudi patient with bilateral facial weakness and scapular winging.
Algahtani H, Shirah B, Algahtani R, Al-Qahtani MH, Abdulkareem AA, Naseer MI
Intractable Rare Dis Res. 2019; 8(2):142-145.
DOI: 10.5582/irdr.2019.01052
-
146-149
Fujimoto Y, Ohya Y, Irie T, Kumamoto S, Tuji A, Nakamura S, Shibata H, Kuramoto K, Hayashi H, Araki Y, Iizaka M, Tomiyasu S, Inomata Y
Intractable Rare Dis Res. 2019; 8(2):146-149.
DOI: 10.5582/irdr.2019.01053
-
150-153
Zhai NX, Lu YQ, Wang YZ, Zhang SE, Peng CM, Zhang SS, Li TY, Chen M, Liu JL, Fang FL, Ren XZ, Han JX
Intractable Rare Dis Res. 2019; 8(2):150-153.
DOI: 10.5582/irdr.2019.01046
-
154-157
Goldston syndrome with congenital hepatic fibrosis: A rare cause of neonatal cholestasis.
Agrwal S, Dabas A, Pal T, Jhamb U
Intractable Rare Dis Res. 2019; 8(2):154-157.
DOI: 10.5582/irdr.2019.01017
-
158-160
The progress of, challenges faced by, and future of rare disease patient organizations in China.
Huang RF, Wei YS, Hu JH, Kong FX, He JJ, Yang Y, Tang M, Jin CL, Kang Q
Intractable Rare Dis Res. 2019; 8(2):158-160.
DOI: 10.5582/irdr.2019.01069
-
161-164
An up-date on novel molecular targets in testicular germ cell tumors subtypes.
Chieffi P
Intractable Rare Dis Res. 2019; 8(2):161-164.
DOI: 10.5582/irdr.2019.01055